2 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Overweight Subjects: new trials by email Literature Review of Overweight Subjects trials Research Report on Overweight Subjects
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects metformin, digoxin, IBI362 - Overweight Subjects, Obese Subjects | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 48 | 2023-04-06 | 2023-11-14 |
| Metformin Induces a Dietary Restriction-like State in Human metformin 0.85 twice daily for 6 months, Calorie restriction - Overweight Subjects, Metformin | Phase 4 | Unknown | Xiang Guang-da | 60 | 2016-04-01 | 2016-04-26 |
| A Study to Investigate the Effect of 7-Keto on Resting Metabolic Rate in Overweight Adults 7-Keto 50mg, 7-Keto 25mg, Placebo - Resting Metabolic Rate, Overweight Subjects | Phase 2 | Completed | KGK Science Inc. | 138 | 2015-09-30 | 2021-04-26 |
Atorvastatin (1) · Caloric Restriction (1) · Digoxin (1) · Metformin (1) · Warfarin (1) · mazdutide (1)
Innovent Biologics (Suzhou) Co. Ltd. (1) · KGK Science Inc. (1) · Xiang Guang-da (1)
China (2) · United States (1)